These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 2992278)
1. A double-blind comparative study of Estraderm and Premarin in the amelioration of postmenopausal symptoms. Place VA; Powers M; Darley PE; Schenkel L; Good WR Am J Obstet Gynecol; 1985 Aug; 152(8):1092-9. PubMed ID: 2992278 [TBL] [Abstract][Full Text] [Related]
2. Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapy. Gordon SF Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 2):998-1004. PubMed ID: 7573298 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women. Hilditch JR; Lewis J; Ross AH; Peter A; van Maris B; Franssen E; Charles J; Norton P; Dunn EV Maturitas; 1996 Jul; 24(3):177-84. PubMed ID: 8844631 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Alora estradiol matrix transdermal delivery system with oral conjugated equine estrogen therapy in relieving menopausal symptoms. Alora Study Group. Good WR; John VA; Ramirez M; Higgins JE Climacteric; 1999 Mar; 2(1):29-36. PubMed ID: 11915854 [TBL] [Abstract][Full Text] [Related]
5. Menorest: a clinical overview. Wren B Int J Gynaecol Obstet; 1996 Mar; 52 Suppl 1():S27-9. PubMed ID: 8666124 [TBL] [Abstract][Full Text] [Related]
6. Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies. Rovati LC; Schmid K; Giacovelli G; Bonn M; Setnikar I; Wolff F; Genazzani AR Arzneimittelforschung; 1999 Nov; 49(11):933-43. PubMed ID: 10604047 [TBL] [Abstract][Full Text] [Related]
7. Clinical experience with transdermal estradiol in the treatment of the climacteric. Utian WH Minerva Endocrinol; 1989; 14(1):45-8. PubMed ID: 2543895 [TBL] [Abstract][Full Text] [Related]
8. A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women. Saure A; Planellas J; Poulsen HK; Jaszczak P Maturitas; 2000 Feb; 34(2):133-42. PubMed ID: 10714908 [TBL] [Abstract][Full Text] [Related]
9. Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptoms. Utian WH; Speroff L; Ellman H; Dart C Menopause; 2005; 12(6):708-15. PubMed ID: 16278614 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of Menorest in two positive-controlled studies. Pornel B Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S35-7. PubMed ID: 8732472 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of climacteric syndrome using Estraderm TTS and premarin in a comparative study]. Leodolter S; Sainz H; Moll-Schüler I; Mach R Gynakol Geburtshilfliche Rundsch; 1992; 32(4):201-4. PubMed ID: 1337708 [TBL] [Abstract][Full Text] [Related]
12. Effect of transdermal 17 beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause. Reginster JY; Christiansen C; Dequinze B; Deroisy R; Gaspard U; Taquet AN; Franchimont P Calcif Tissue Int; 1993 Jul; 53(1):13-6. PubMed ID: 8394191 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 beta-estradiol: comparison with conventional oral estrogens used for hormone replacement. Powers MS; Schenkel L; Darley PE; Good WR; Balestra JC; Place VA Am J Obstet Gynecol; 1985 Aug; 152(8):1099-106. PubMed ID: 2992279 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of transdermal with oral hormone substitution: a multicenter study with a new matrix patch]. Sajtos B; Herold J; Winkler UH; Schindler AE Zentralbl Gynakol; 1995; 117(10):524-30. PubMed ID: 7491835 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of a seven-day, transdermal estradiol drug-delivery system: comparison with conjugated estrogens and placebo. The Transdermal Estradiol Patch Study Group. Gordon SF; Thompson KA; Ruoff GE; Imig JR; Lane PJ; Schwenker CE Int J Fertil Menopausal Stud; 1995; 40(3):126-34. PubMed ID: 7663539 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of Menorest (50 mikrog/day) compared to Premarin 0.625 mg in the treatment of menopausal symptoms and the prevention of bone loss, in menopausal women. A single-center, comparative, randomized, double-blind, double-dummy study. Studd JW; MacCarthy K; Zamblera D; Dain MP Scand J Rheumatol Suppl; 1996; 103():89-90. PubMed ID: 8966497 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of estradiol vaginal cream in postmenopausal women. Dickerson J; Bressler R; Christian CD; Hermann HW Clin Pharmacol Ther; 1979 Oct; 26(4):502-7. PubMed ID: 226306 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerance of Menorest compared to Premarin in the treatment of postmenopausal women. A randomised, multicentre, double-blind, double-dummy study. Studd JW; McCarthy K; Zamblera D; Burger HG; Silberberg S; Wren B; Dain MP; Le Lann L; Vandepol C Maturitas; 1995 Sep; 22(2):105-14. PubMed ID: 8538478 [TBL] [Abstract][Full Text] [Related]
19. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. Nelson HD JAMA; 2004 Apr; 291(13):1610-20. PubMed ID: 15069049 [TBL] [Abstract][Full Text] [Related]
20. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study. Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]